Bibliography
- IOosterhuis, Fvan Hunsel, Evan Puijenbroek. Expectations for feedback in adverse drug reporting by healthcare professionals in the Netherlands. Drug Saf 2012;35(3):221–31
- Kvan Grootheest, KMes, Lde Jong-van den Berg. Attitudes of community pharmacists in the Netherlands towards adverse drug reaction reporting. Int J Pharm Pr 2002;10:267–72
- SMWallerstedt, GBrunlof, MLJohansson, et al. Reporting of adverse drug reactions may be influenced by feedback to the reporting doctor. Eur J Clin Pharmacol 2007;63(5):505–8
- ACvan Grootheest. Improving pharmacovigilance and the role of the pharmacist 2003; Thesis Rijksuniversiteit Groningen
- FMargraff, DBertram. Adverse drug reaction reporting by patients: an overview of fifty countries. Drug Saf 2014;37(6):409–19
- Fvan Hunsel, LHärmark, SPal, et al. Experiences with adverse drug reaction reporting by patients; An 11-country survey. Drug Saf 2012;35(1):45–60
- DJMcLernon, CMBond, AJLee, et al. Patient views and experiences of making adverse drug reaction reports to the yellow card scheme in the UK. Pharmacoepidemiol Drug Saf 2011;20(5):523–31
- Fvan Hunsel, Cvan der Welle, APassier, et al. Motives for reporting adverse drug reactions by patient-reporters in the Netherlands. Eur J Clin Pharmacol 2010;66(11):1143–50
- The EU Pharmacogivilance system [online]. The European Commission (EM). [Last accessed 10 June 2013]
- Netherlands pharmacovigilance centre Lareb. Lareb annual report. 2003. Available from: http://www.lareb.nl/getmedia/160a9a1b-b36a-4e07-b0df-abb65384dcac/jaarverslag2003.pdf [Last accessed 3 May 2013]
- Netherlands Pharmacovigilance Centre Lareb. Lareb annual report. 2010. Available from: http://www.lareb.nl/getmedia/79575982-de61-40cb-8650-67b33f9c78b9/Lareb_jaarbericht_2010.pdf [Last accessed 3 May 2013]
- Netherlands Pharmacovigilance Centre Lareb. Lareb annual report. 2012. Available from: http://www.lareb.nl/getmedia/61b4572b-2922-4ed2-b4ae-b1c21bca060d/Jaarbericht-2012.pdf [Last accessed 16 May 2013]
- CIOMS Working Groups V. Current Challenges in Pharmacovigilance: Pragmatic Approaches, III Good case management practives, Criteria for seriousness. Council for Internaitonal Organizations of Medical Sciences (CIOMS), Switzerland. 2001;99–100
- Survey Monkey. Available from: http://www.surveymonckey.com [Last accessed 30 July 2012]
- CWinship, RDMare. Regression models with ordinal variables. Am Socialog Rev 1984;49:512–25
- The Central Committee on Research Involving Human Subjects (CCMO). Guideline CCMO. Available from: http://www.ccmo-online.nl/main.asp?pid=1&taal= [Last accessed 12 September 2011]
- SElo, HKyngäs. The qualitative content analysis process. J Adv Nurs 2007;62(1):107–15
- AKBanerjee, SOkun, IREdwards, et al. Patient-reported outcome measures in safety event reporting: prosper consortium guidance. Drug Saf 2013;36(12):1129–49
- Statistics Netherlands. Available from: www.cbs.nl [Last accessed 17 May 2013]
- Dutch Ministry of Education Culture and Science Level of education of Dutch population. Available from: http://www.trendsinbeeld.minocw.nl/grafieken/3_1_2_31.php [Last accessed 1 July 2013]